Dimethyl fumarate treatment in relapsing remitting MS changes the inflammatory CSF protein profile by a prominent decrease in T-helper 1 immunity
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dimethyl fumarate treatment in relapsing remitting MS changes the inflammatory CSF protein profile by a prominent decrease in T-helper 1 immunity
Authors
Keywords
-
Journal
Multiple Sclerosis and Related Disorders
Volume -, Issue -, Pages 105126
Publisher
Elsevier BV
Online
2023-11-06
DOI
10.1016/j.msard.2023.105126
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of early neurodegenerative pathways in progressive multiple sclerosis
- (2022) Max Kaufmann et al. NATURE NEUROSCIENCE
- High-dimensional immune profiling identifies a biomarker to monitor dimethyl fumarate response in multiple sclerosis
- (2022) Martin Diebold et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunological effects of dimethyl fumarate treatment in blood and CSF of patients with primary progressive MS
- (2021) J. Talbot et al. JOURNAL OF NEUROIMMUNOLOGY
- Inflammation-related plasma and CSF biomarkers for multiple sclerosis
- (2020) Jesse Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Current and emerging disease‐modulatory therapies and treatment targets for multiple sclerosis
- (2020) F. Piehl JOURNAL OF INTERNAL MEDICINE
- Semaphorin4A causes loss of mature oligodendrocytes and demyelination in vivo
- (2019) Brian Chiou et al. Journal of Neuroinflammation
- GM-CSF and CXCR4 define a T helper cell signature in multiple sclerosis
- (2019) Edoardo Galli et al. NATURE MEDICINE
- Dimethyl Fumarate: A Review in Relapsing-Remitting MS
- (2019) Hannah A. Blair DRUGS
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
- (2018) Alan J Thompson et al. LANCET NEUROLOGY
- Dimethyl fumarate treatment in multiple sclerosis: Recent advances in clinical and immunological studies
- (2018) Gwendoline Montes Diaz et al. AUTOIMMUNITY REVIEWS
- STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
- (2018) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- Dimethyl Fumarate Selectively Reduces Memory T Cells and Shifts the Balance between Th1/Th17 and Th2 in Multiple Sclerosis Patients
- (2017) Qi Wu et al. JOURNAL OF IMMUNOLOGY
- Nrf2, cellular redox regulation, and neurologic implications
- (2017) Eduardo E. Benarroch NEUROLOGY
- Pharmacodynamics of Dimethyl Fumarate Are Tissue Specific and Involve NRF2-Dependent and -Independent Mechanisms
- (2016) Melanie S. Brennan et al. ANTIOXIDANTS & REDOX SIGNALING
- Complex heatmaps reveal patterns and correlations in multidimensional genomic data
- (2016) Zuguang Gu et al. BIOINFORMATICS
- Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients
- (2015) Erin E Longbrake et al. Multiple Sclerosis Journal
- NAD+ in aging, metabolism, and neurodegeneration
- (2015) E. Verdin SCIENCE
- Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients
- (2015) Erin E Longbrake et al. Multiple Sclerosis Journal
- Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate’s protective effect in EAE
- (2014) Hui Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Semaphorins and plexins as therapeutic targets
- (2014) Thomas Worzfeld et al. NATURE REVIEWS DRUG DISCOVERY
- Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability
- (2014) Erika Assarsson et al. PLoS One
- The Role of Neurotrophins in Multiple Sclerosis—Pathological and Clinical Implications
- (2012) Alicja Kalinowska-Lyszczarz et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Elevation of Sema4A Implicates Th Cell Skewing and the Efficacy of IFN- Therapy in Multiple Sclerosis
- (2012) Y. Nakatsuji et al. JOURNAL OF IMMUNOLOGY
- Interleukins, from 1 to 37, and interferon-γ: Receptors, functions, and roles in diseases
- (2011) Mübeccel Akdis et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Roles of Sema4D-Plexin-B1 Interactions in the Central Nervous System for Pathogenesis of Experimental Autoimmune Encephalomyelitis
- (2009) T. Okuno et al. JOURNAL OF IMMUNOLOGY
- Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study
- (2009) Eva Havrdova et al. LANCET NEUROLOGY
- Homeostasis of Naive and Memory T Cells
- (2008) Charles D. Surh et al. IMMUNITY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started